1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Extended Release Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Sustained Release Drug 1.2.3 Controlled Release Drug 1.3 Market by Application 1.3.1 Global Extended Release Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Online Pharmacy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Extended Release Drug Market Perspective (2016-2027) 2.2 Extended Release Drug Growth Trends by Regions 2.2.1 Extended Release Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Extended Release Drug Historic Market Share by Regions (2016-2021) 2.2.3 Extended Release Drug Forecasted Market Size by Regions (2022-2027) 2.3 Extended Release Drug Industry Dynamic 2.3.1 Extended Release Drug Market Trends 2.3.2 Extended Release Drug Market Drivers 2.3.3 Extended Release Drug Market Challenges 2.3.4 Extended Release Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Extended Release Drug Players by Revenue 3.1.1 Global Top Extended Release Drug Players by Revenue (2016-2021) 3.1.2 Global Extended Release Drug Revenue Market Share by Players (2016-2021) 3.2 Global Extended Release Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Extended Release Drug Revenue 3.4 Global Extended Release Drug Market Concentration Ratio 3.4.1 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Extended Release Drug Revenue in 2020 3.5 Extended Release Drug Key Players Head office and Area Served 3.6 Key Players Extended Release Drug Product Solution and Service 3.7 Date of Enter into Extended Release Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Extended Release Drug Breakdown Data by Type 4.1 Global Extended Release Drug Historic Market Size by Type (2016-2021) 4.2 Global Extended Release Drug Forecasted Market Size by Type (2022-2027) 5 Extended Release Drug Breakdown Data by Application 5.1 Global Extended Release Drug Historic Market Size by Application (2016-2021) 5.2 Global Extended Release Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Extended Release Drug Market Size (2016-2027) 6.2 North America Extended Release Drug Market Size by Type 6.2.1 North America Extended Release Drug Market Size by Type (2016-2021) 6.2.2 North America Extended Release Drug Market Size by Type (2022-2027) 6.2.3 North America Extended Release Drug Market Size by Type (2016-2027) 6.3 North America Extended Release Drug Market Size by Application 6.3.1 North America Extended Release Drug Market Size by Application (2016-2021) 6.3.2 North America Extended Release Drug Market Size by Application (2022-2027) 6.3.3 North America Extended Release Drug Market Size by Application (2016-2027) 6.4 North America Extended Release Drug Market Size by Country 6.4.1 North America Extended Release Drug Market Size by Country (2016-2021) 6.4.2 North America Extended Release Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Extended Release Drug Market Size (2016-2027) 7.2 Europe Extended Release Drug Market Size by Type 7.2.1 Europe Extended Release Drug Market Size by Type (2016-2021) 7.2.2 Europe Extended Release Drug Market Size by Type (2022-2027) 7.2.3 Europe Extended Release Drug Market Size by Type (2016-2027) 7.3 Europe Extended Release Drug Market Size by Application 7.3.1 Europe Extended Release Drug Market Size by Application (2016-2021) 7.3.2 Europe Extended Release Drug Market Size by Application (2022-2027) 7.3.3 Europe Extended Release Drug Market Size by Application (2016-2027) 7.4 Europe Extended Release Drug Market Size by Country 7.4.1 Europe Extended Release Drug Market Size by Country (2016-2021) 7.4.2 Europe Extended Release Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Extended Release Drug Market Size (2016-2027) 8.2 Asia-Pacific Extended Release Drug Market Size by Type 8.2.1 Asia-Pacific Extended Release Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Extended Release Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Extended Release Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Extended Release Drug Market Size by Application 8.3.1 Asia-Pacific Extended Release Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Extended Release Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Extended Release Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Extended Release Drug Market Size by Region 8.4.1 Asia-Pacific Extended Release Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Extended Release Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Extended Release Drug Market Size (2016-2027) 9.2 Latin America Extended Release Drug Market Size by Type 9.2.1 Latin America Extended Release Drug Market Size by Type (2016-2021) 9.2.2 Latin America Extended Release Drug Market Size by Type (2022-2027) 9.2.3 Latin America Extended Release Drug Market Size by Type (2016-2027) 9.3 Latin America Extended Release Drug Market Size by Application 9.3.1 Latin America Extended Release Drug Market Size by Application (2016-2021) 9.3.2 Latin America Extended Release Drug Market Size by Application (2022-2027) 9.3.3 Latin America Extended Release Drug Market Size by Application (2016-2027) 9.4 Latin America Extended Release Drug Market Size by Country 9.4.1 Latin America Extended Release Drug Market Size by Country (2016-2021) 9.4.2 Latin America Extended Release Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Extended Release Drug Market Size (2016-2027) 10.2 Middle East & Africa Extended Release Drug Market Size by Type 10.2.1 Middle East & Africa Extended Release Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Extended Release Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Extended Release Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Extended Release Drug Market Size by Application 10.3.1 Middle East & Africa Extended Release Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Extended Release Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Extended Release Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Extended Release Drug Market Size by Country 10.4.1 Middle East & Africa Extended Release Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Extended Release Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Extended Release Drug Introduction 11.1.4 Pfizer Revenue in Extended Release Drug Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Mallinckrodt 11.2.1 Mallinckrodt Company Details 11.2.2 Mallinckrodt Business Overview 11.2.3 Mallinckrodt Extended Release Drug Introduction 11.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2016-2021) 11.2.5 Mallinckrodt Recent Development 11.3 Teva 11.3.1 Teva Company Details 11.3.2 Teva Business Overview 11.3.3 Teva Extended Release Drug Introduction 11.3.4 Teva Revenue in Extended Release Drug Business (2016-2021) 11.3.5 Teva Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Extended Release Drug Introduction 11.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2016-2021) 11.4.5 Johnson & Johnson Recent Development 11.5 Endo Pharmaceuticals 11.5.1 Endo Pharmaceuticals Company Details 11.5.2 Endo Pharmaceuticals Business Overview 11.5.3 Endo Pharmaceuticals Extended Release Drug Introduction 11.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2016-2021) 11.5.5 Endo Pharmaceuticals Recent Development 11.6 Purdue Pharma 11.6.1 Purdue Pharma Company Details 11.6.2 Purdue Pharma Business Overview 11.6.3 Purdue Pharma Extended Release Drug Introduction 11.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2016-2021) 11.6.5 Purdue Pharma Recent Development 11.7 Mylan 11.7.1 Mylan Company Details 11.7.2 Mylan Business Overview 11.7.3 Mylan Extended Release Drug Introduction 11.7.4 Mylan Revenue in Extended Release Drug Business (2016-2021) 11.7.5 Mylan Recent Development 11.8 Hisamitsu Pharmaceutical 11.8.1 Hisamitsu Pharmaceutical Company Details 11.8.2 Hisamitsu Pharmaceutical Business Overview 11.8.3 Hisamitsu Pharmaceutical Extended Release Drug Introduction 11.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2016-2021) 11.8.5 Hisamitsu Pharmaceutical Recent Development 11.9 Sun Pharmaceutical Industries 11.9.1 Sun Pharmaceutical Industries Company Details 11.9.2 Sun Pharmaceutical Industries Business Overview 11.9.3 Sun Pharmaceutical Industries Extended Release Drug Introduction 11.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2016-2021) 11.9.5 Sun Pharmaceutical Industries Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Extended Release Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Sustained Release Drug Table 3. Key Players of Controlled Release Drug Table 4. Global Extended Release Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Extended Release Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Extended Release Drug Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Extended Release Drug Market Share by Regions (2016-2021) Table 8. Global Extended Release Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Extended Release Drug Market Share by Regions (2022-2027) Table 10. Extended Release Drug Market Trends Table 11. Extended Release Drug Market Drivers Table 12. Extended Release Drug Market Challenges Table 13. Extended Release Drug Market Restraints Table 14. Global Extended Release Drug Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Extended Release Drug Market Share by Players (2016-2021) Table 16. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2020) Table 17. Ranking of Global Top Extended Release Drug Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Extended Release Drug Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Extended Release Drug Product Solution and Service Table 21. Date of Enter into Extended Release Drug Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Extended Release Drug Market Size by Type (2016-2021) (US$ Million) Table 24. Global Extended Release Drug Revenue Market Share by Type (2016-2021) Table 25. Global Extended Release Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Extended Release Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Extended Release Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Extended Release Drug Revenue Market Share by Application (2016-2021) Table 29. Global Extended Release Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Extended Release Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Extended Release Drug Market Size by Type (2016-2021) (US$ Million) Table 32. North America Extended Release Drug Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Extended Release Drug Market Size by Application (2016-2021) (US$ Million) Table 34. North America Extended Release Drug Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Extended Release Drug Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Extended Release Drug Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Extended Release Drug Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Extended Release Drug Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Extended Release Drug Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Extended Release Drug Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Extended Release Drug Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Extended Release Drug Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Extended Release Drug Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Extended Release Drug Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Extended Release Drug Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Extended Release Drug Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Extended Release Drug Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Extended Release Drug Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Extended Release Drug Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Extended Release Drug Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Extended Release Drug Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Extended Release Drug Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Extended Release Drug Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Extended Release Drug Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Extended Release Drug Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Extended Release Drug Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Extended Release Drug Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Extended Release Drug Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Extended Release Drug Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Extended Release Drug Market Size by Country (2022-2027) & (US$ Million) Table 61. Pfizer Company Details Table 62. Pfizer Business Overview Table 63. Pfizer Extended Release Drug Product Table 64. Pfizer Revenue in Extended Release Drug Business (2016-2021) & (US$ Million) Table 65. Pfizer Recent Development Table 66. Mallinckrodt Company Details Table 67. Mallinckrodt Business Overview Table 68. Mallinckrodt Extended Release Drug Product Table 69. Mallinckrodt Revenue in Extended Release Drug Business (2016-2021) & (US$ Million) Table 70. Mallinckrodt Recent Development Table 71. Teva Company Details Table 72. Teva Business Overview Table 73. Teva Extended Release Drug Product Table 74. Teva Revenue in Extended Release Drug Business (2016-2021) & (US$ Million) Table 75. Teva Recent Development Table 76. Johnson & Johnson Company Details Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Extended Release Drug Product Table 79. Johnson & Johnson Revenue in Extended Release Drug Business (2016-2021) & (US$ Million) Table 80. Johnson & Johnson Recent Development Table 81. Endo Pharmaceuticals Company Details Table 82. Endo Pharmaceuticals Business Overview Table 83. Endo Pharmaceuticals Extended Release Drug Product Table 84. Endo Pharmaceuticals Revenue in Extended Release Drug Business (2016-2021) & (US$ Million) Table 85. Endo Pharmaceuticals Recent Development Table 86. Purdue Pharma Company Details Table 87. Purdue Pharma Business Overview Table 88. Purdue Pharma Extended Release Drug Product Table 89. Purdue Pharma Revenue in Extended Release Drug Business (2016-2021) & (US$ Million) Table 90. Purdue Pharma Recent Development Table 91. Mylan Company Details Table 92. Mylan Business Overview Table 93. Mylan Extended Release Drug Product Table 94. Mylan Revenue in Extended Release Drug Business (2016-2021) & (US$ Million) Table 95. Mylan Recent Development Table 96. Hisamitsu Pharmaceutical Company Details Table 97. Hisamitsu Pharmaceutical Business Overview Table 98. Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2016-2021) & (US$ Million) Table 99. Hisamitsu Pharmaceutical Recent Development Table 100. Sun Pharmaceutical Industries Company Details Table 101. Sun Pharmaceutical Industries Business Overview Table 102. Sun Pharmaceutical Industries Extended Release Drug Product Table 103. Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2016-2021) & (US$ Million) Table 104. Sun Pharmaceutical Industries Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Extended Release Drug Market Share by Type: 2020 VS 2027 Figure 2. Sustained Release Drug Features Figure 3. Controlled Release Drug Features Figure 4. Global Extended Release Drug Market Share by Application: 2020 VS 2027 Figure 5. Hospital Pharmacy Case Studies Figure 6. Retail Pharmacy Case Studies Figure 7. Online Pharmacy Case Studies Figure 8. Extended Release Drug Report Years Considered Figure 9. Global Extended Release Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Extended Release Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Extended Release Drug Market Share by Regions: 2020 VS 2027 Figure 12. Global Extended Release Drug Market Share by Regions (2022-2027) Figure 13. Global Extended Release Drug Market Share by Players in 2020 Figure 14. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Extended Release Drug Revenue in 2020 Figure 16. Global Extended Release Drug Revenue Market Share by Type (2016-2021) Figure 17. Global Extended Release Drug Revenue Market Share by Type (2022-2027) Figure 18. North America Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Extended Release Drug Market Share by Type (2016-2027) Figure 20. North America Extended Release Drug Market Share by Application (2016-2027) Figure 21. North America Extended Release Drug Market Share by Country (2016-2027) Figure 22. United States Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Extended Release Drug Market Share by Type (2016-2027) Figure 26. Europe Extended Release Drug Market Share by Application (2016-2027) Figure 27. Europe Extended Release Drug Market Share by Country (2016-2027) Figure 28. Germany Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Extended Release Drug Market Share by Type (2016-2027) Figure 36. Asia-Pacific Extended Release Drug Market Share by Application (2016-2027) Figure 37. Asia-Pacific Extended Release Drug Market Share by Region (2016-2027) Figure 38. China Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Extended Release Drug Market Share by Type (2016-2027) Figure 46. Latin America Extended Release Drug Market Share by Application (2016-2027) Figure 47. Latin America Extended Release Drug Market Share by Country (2016-2027) Figure 48. Mexico Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Extended Release Drug Market Share by Type (2016-2027) Figure 52. Middle East & Africa Extended Release Drug Market Share by Application (2016-2027) Figure 53. Middle East & Africa Extended Release Drug Market Share by Country (2016-2027) Figure 54. Turkey Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Pfizer Revenue Growth Rate in Extended Release Drug Business (2016-2021) Figure 58. Mallinckrodt Revenue Growth Rate in Extended Release Drug Business (2016-2021) Figure 59. Teva Revenue Growth Rate in Extended Release Drug Business (2016-2021) Figure 60. Johnson & Johnson Revenue Growth Rate in Extended Release Drug Business (2016-2021) Figure 61. Endo Pharmaceuticals Revenue Growth Rate in Extended Release Drug Business (2016-2021) Figure 62. Purdue Pharma Revenue Growth Rate in Extended Release Drug Business (2016-2021) Figure 63. Mylan Revenue Growth Rate in Extended Release Drug Business (2016-2021) Figure 64. Hisamitsu Pharmaceutical Revenue Growth Rate in Extended Release Drug Business (2016-2021) Figure 65. Sun Pharmaceutical Industries Revenue Growth Rate in Extended Release Drug Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Pfizer Mallinckrodt Teva Johnson & Johnson Endo Pharmaceuticals Purdue Pharma Mylan Hisamitsu Pharmaceutical Sun Pharmaceutical Industries